Beam Therapeutics Inc.

NASDAQ: BEAM
Share price (12/20/24): $29.01
Market cap (12/20/24): $2.402 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Ciaramella Giuseppe

Emany Sravan Kumar

News Filter

Announces New Data From BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

Announces Appointment of Sravan Emany as Chief Financial Officer

Expands Its Board of Directors With Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader

To Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-Human Primate Data, at American Society of Hematology (ASH) Annual Meeting

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC